LEADER 01729oam  2200445   450 
001 9910706275003321
005 20180312151721.0
035   $a(CKB)5470000002455685
035   $a(OCoLC)1005355835
035   $a(EXLCZ)995470000002455685
100   $a20171005d2017      ua             0
101 0 $aeng
135   $aurbn||||a||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 14$aThe Obama administration's Medicare drug experiment $ethe patient and doctor perspective : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Fourteenth Congress, second session, May 17, 2016
210  1$aWashington :$cU.S. Government Publishing Office,$d2017.
215   $a1 online resource (v, 273 pages) $cillustrations
300   $aPaper version available for sale by the Superintendent of Documents, U.S. Government Publishing Office.
300   $a"Serial no. 114-146."
320   $aIncludes bibliographical references.
517   $aObama administration's Medicare drug experiment 
606   $aDrugs$xPrices$xGovernment policy$zUnited States
606   $aPharmaceutical services insurance$zUnited States
606   $aMedicare$xClaims administration
608   $aLegislative hearings.$2lcgft
615  0$aDrugs$xPrices$xGovernment policy
615  0$aPharmaceutical services insurance
615  0$aMedicare$xClaims administration.
801  0$bGPO
801  1$bGPO
801  2$bGPO
801  2$bMERUC
801  2$bOCLCF
801  2$bGPO
906   $aBOOK
912   $a9910706275003321
996   $aThe Obama administration's Medicare drug experiment$93442172
997   $aUNINA